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Spontaneous Ca2 oscillations have been observed in a num-
ber of excitable and non-excitable cells, but in most cases their
biological role remains elusive. In the present study we demon-
strate that spontaneous Ca2 oscillations occur in immature
human monocyte-derived dendritic cells but not in dendritic
cells stimulated to undergomaturation with lipopolysaccharide
or other toll like-receptor agonists. We investigated the mecha-
nism and role of spontaneous Ca2 oscillations in immature
dendritic cells and found that they are mediated by the inositol
1,4,5-trisphosphate receptor as they were blocked by pretreat-
ment of cells with the inositol 1,4,5-trisphosphate receptor
antagonist Xestospongin C and 2-aminoethoxydiphenylborate.
A component of the Ca2 signal is also due to influx from the
extracellular environment and may be involved in maintaining
the level of the intracellular Ca2 stores. As to their biological
role, our results indicate that they are intimately linked to the
“immature” phenotype and are associated with the transloca-
tion of the transcription factor NFAT into the nucleus. In fact,
once the Ca2 oscillations are blocked with 2-aminoethoxydi-
phenylborate or by treating the cells with lipopolysaccharide,
NFAT remains cytoplasmic. The results presented in this report
provide novel insights into the physiology of monocyte-derived
dendritic cells and into themechanisms involved inmaintaining
the cells in the immature stage.
Dendritic cells (DCs)2 are the most potent antigen present-
ing cells and are thought to be the initiators and modulators of
the immune response (1). In general, DCs exist in two forms,
immature DCs (iDC) and mature DCs. Immature DCs are
extremely efficient at endocytosis; they reside in the peripheral
tissues and continuously sample their environment for the
presence of foreign antigens. After capturing antigens, they
become activated and migrate to the lymphoid tissues and in
the process lose the ability to take up new antigens, increase
their surface expression of major histocompatibility complex II
molecules and co-stimulatory molecules involved in antigen
presentation to T cells, and reach their full maturation stage
(1–3). Although generally correct, this picture is nowproving to
be too simple. For example, it was recently found that iDCs are
also involved in induction and maintenance of T cell tolerance
in peripheral tissues (4).
Immature DCs, produced by culturing monocytes for 5 days
in medium containing granulocyte-macrophage stimulating
factor and interleukin-4 (IL-4), are phenotypically, morpholog-
ically, and functionally identical with iDCs occurring in vivo (5).
Their maturation is controlled by Toll-like receptors (TLRs),
one of the best characterized classes of pattern recognition
receptors of mammalian species. Most mammalian species
express about 10–15 different TLRs that are encoded by a yet to
be defined number of genes. Interestingly, distinct subsets of
DCs express different TLRs, and their engagement results in
DC maturation (6). In fact, monocyte-derived DCs can be
induced to mature very efficiently by incubating them with
nanogram to microgram (per ml) concentrations of lipopo-
lysaccharide (LPS) through engagement of TLR4 receptors (7).
In addition, other ligands such as the synthetic TLR7 ligand
imidazoquinoline, a reagent already used as adjuvant in the
treatment of viral infections and skin tumors (8–10), can also
induce maturation of iDCs in vitro. The signaling pathways
leading to DC maturation are complex and involve nuclear
translocation of the transcription factor NF-B as well as
increases in the cytoplasmic Ca2 concentration ([Ca2]) (11–
15). Ca2 is one of the most ubiquitous second messengers
underlying cellular responses such as secretion,motility, prolif-
eration, and death. Interestingly, Ca2-sensitive transcription
factors including NFAT and NF-B regulate the expression of
Ca2-sensitive genes including IL-2, IL-3, IL-4, tumor necrosis
factor-, and interferon- (16, 17). Some cell types exhibit
oscillatory changes of their cytosolic Ca2, and these have been
correlated to a variety of cellular functions. For example, in
T-cells, dependingon their frequency, oscillations triggerCa2-
dependent activation of the transcription factors NFAT,
NF-B, and c-JunN-terminal kinase (JNK) (18). In human bone
marrow-derived mesenchymal stem cells, Ca2 oscillations
have been implicated in differentiation (19), in embryonic stem
cell-derived primitive endodermal cells, oscillations have been
implicated in the exo/endocytotic vesicle shuttle (20), and in
human astrocytoma cells Ca2 oscillations have been impli-
cated in cell migration (21). Ca2 signaling is also known to be
involved in the regulation of immune cell function, and its
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importance is emphasized by the fact that most immune cells
including DCs express several classes of Ca2 channels on their
plasma membrane (22) as well as intracellular Ca2 channels
belonging to the InsP3R and ryanodine receptor family (23–28).
In this context it is worth mentioning that the involvement of
Ca2 signaling events inDCmaturation has been postulated for
a number of years (14, 15), and we recently demonstrated that
ryanodine receptor 1-mediated Ca2 signals can act synergisti-
cally with signals generated via Toll-like receptors driving DC
maturation (26, 27).
In the present report we show that spontaneous Ca2 oscil-
lations occur in iDCs. These oscillations occur only in iDCs and
are lost during the maturation process, and their abrogation
leads to the cytoplasmic localization of endogenousNFAT. The
results of this study offer additional insights into some of the
signaling processes controlling maturation of DCs.
MATERIALS ANDMETHODS
Generation of Dendritic Cells—iDCs were generated from
human peripheral blood mononuclear cells as previously
described (29). Briefly, monocytes were purified by positive
sorting using anti-CD14-conjugated magnetic microbeads
(Miltenyi Biotech, Bergisch Gladbach, Germany). The recov-
ered cells (95–98% purity) were cultured for 5 days at 3–4 
105/ml in differentiation medium containing RPMI with 10%
fetal calf serum, glutamine, nonessential amino acids, and anti-
biotics (all from Invitrogen) supplemented with 50 ng/ml gran-
ulocyte-macrophage stimulating factor (Laboratory Pablo Cas-
sara`, Buenos Aires, Argentina) and 1000 units/ml IL-4 (a gift
from A. Lanzavecchia, Institute for Research in Biomedicine,
Bellinzona, Switzerland). Maturation was induced by the addi-
tion of LPS 1 g/ml (from Salmonella abortus equi, Sigma) to
the culture medium. In some experiments DC maturation was
induced by the addition of the synthetic TLR7 agonist, imida-
zoquinoline (3M-001) (final concentration 3 M), that was
kindly provided by 3M Pharmaceuticals (St. Paul, MN).
Single Cell Intracellular Ca2 Measurements—Ca2 mea-
surements were performed on DCs loaded with fast Ca2 indi-
cator fluo-4 (Invitrogen; 5 M final concentration). In some
experiments cells were incubated with 100M 2-aminoethoxy-
diphenylborate (2-APB) (Calbiochem), 1 M Xestospongin C
(Calbiochem), or 2 M thapsigargin with 0.5 mM EGTA during
the loading procedure. After loading, cells were rinsed once,
resuspended in Krebs-Ringer medium, and allowed to adhere
to poly-L-lysine (1:60 dilution) (Sigma)-treated glass coverslips
that were than mounted onto a 37 °C thermostatted chamber.
On-line epifluorescence images were acquired every 100ms for
50 s using a Nikon Eclipse TE2000-E fluorescent microscope
equipped with an oil immersion CFI Plan Apochromat 60
TIRF objective (1.45 numerical aperture). Changes in fluores-
cence were detected by exciting at 488 nm and recording the
emission at 510 nm via an electron multiplier C9100–13
Hamamatsu CCD camera which allows fast data acquisition
(maximal temporal resolution 1 frame (110 110 pixels/8 ms).
Where indicated, either 1g/ml LPS or 2MU73122 (BioMol)
was added during the measurements. To investigate the
dynamics of Ca2influx, we measured fluorescent changes in
the TIRF mode; first we identified the focal plane at the cover-
glass/cell membrane contact with a surface reflective interfer-
ence contrast filter, and this focal plane was maintained
throughout the recordings bymeans of the perfect focus system
that exploits an infrared laser beam and a quadrant diode for
online control of the microscope focusing motor. Image analy-
sis was performed with the MetaMorph (Molecular Devices)
software package.
Endocytosis and Quantitative Gene Expression Analysis—
Endocytosis was followed by incubating DCs in RPMI medium
containing 0.5 mg/ml fluorescein isothiocyanate (FITC)-la-
beled dextran (Fluka Biochemicals, Buchs, Switzerland) for 30
min at 37 °C. Cells were washed twice in ice-cold phosphate-
buffered saline fixed with 1% paraformaldehyde, and the num-
ber of FITC-positive cells was assessed by flow cytometry. In
some experiments, before incubation with FITC-dextran, cells
were treated for 45 min with 100 M 2-APB or with LPS (1
g/ml) or with the TLR-7 agonist 3M-001 (3M) for 18 h. Gene
expression was quantified by real time PCR as previously
described (26). Briefly, 1–2 106 iDCs were incubated for 18 h
with 1MXestosponginC, 100M2-APB, 3M imidazoquino-
line (3M-001), or 1 g/ml LPS. Total RNA was extracted and
treated with deoxyribonuclease I (Invitrogen) to eliminate con-
taminant genomic DNA. After reverse transcription using 500
ng of RNA and the Moloney murine leukemia virus reverse
transcriptase (Invitrogen), cDNAwas amplified by quantitative
real-time PCR in the ABI PrismTM7700 using the TaqMan
technology. Commercially available exon-intron junction-de-
signed primers for glyceraldehyde-3-phosphate dehydrogen-
ase, CD83, CD80 CD86, interferon-, and IL23A (Applied Bio-
systems, Forster City, CA) were used. Gene expression was
normalized using self-glyceraldehyde-3-phosphate dehydro-
genase as reference (26). The data from DCs isolated from five
donors were pooled and are expressed as -fold increase in gene
expression compared with untreated iDCs.
Immunofluorescence—Indirect immunofluorescence was
performed onmethanol:acetone (1:1)-fixed DCs using rabbit
anti-NFATc1 (sc-13033) or rabbit anti- NF-B p65 antibody
(sc-109, Santa Cruz Biotechnology) followed by Alexa fluor
488-conjugated chicken anti-rabbit antibody (Invitrogen).
Nuclei were visualized by 4 6-diamidino-2-phenylindole, dihy-
drochloride (DAPI; 100 M) (Invitrogen) staining. Fluores-
cence was detected using a fluorescent Axiovert S100 TV
inverted microscope (Carl Zeiss GmbH, Jena, Germany)
equippedwith an40 FLUARobjective andZeiss filter sets (BP
475/40, FT 500, and BP 530/50; BP 546, FT 560, and 575–640)
for detection of DAPI and FITC fluorescence, respectively.
Immunoblotting Analysis—The cytosolic fraction of 6 106
DCswas extracted as described byHealy et al. (30). Briefly, cells
were washed once and resuspended in 50 l of ice-cold buffer
containing 20mMHEPES, pH 7.5, 5mMNaCl, and 2mM EDTA
to which 50 l of 20 mM HEPES, pH 7.5, 4 mM NaCl, 2 mM
EDTA, and 0.8% Nonidet P-40 were added. Cells were incu-
bated on ice for 2min, and the nuclear andmembrane fractions
were removed by centrifugation (600  g, 10 min, 4 °C). Lae-
mmli loading buffer (10% glycerol, 1% -mercaptoethanol, 2%
SDS, 65 mM Tris-HCl, pH 6.8) was added to the supernatant
(cytosolic fraction) which was boiled for 5 min and then loaded
onto a 7.5% SDS-polyacrylamide gel. Proteins were transferred
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onto nitrocellulose, and the blots
were probed with a rabbit anti-
NFATc1 antibody (1:500; sc-13033,
Santa Cruz Biotechnology) followed
by peroxidase-conjugated proteinG
(1:250,000) and with mouse anti-
tubulin (Santa Cruz sc-5274) fol-
lowedbyperoxidase-conjugatedanti-
mouse IgG (1:200,000). The immu-
nopositive bands were visualized by
autoradiography using the Super
Signal West Dura chemilumines-
cence kit from Thermo Scientific
(for NFAT) and BM chemilumines-
cence kit from Roche Applied Sci-
ence (for -tubulin).
Statistical Analysis and Software
Programs—Statistical analysis was
performed using Student’s t test for
paired samples; means were consid-
ered statistically significant when
the p value was 0.05. When more
than two samples were compared,
analysis was performed by the
ANOVA test followed by the Bon-
ferroni post hoc test. The PROC
MIXED statistical analysis program
(SAS 9.2) on log-transformed data
were used for real-time PCR gene
expression analysis from indepen-
dent biological replicates. The Origin
computer program (Microcal Soft-
ware, Inc., Northampton, MA) was
used to generate graphs and for sta-
tistical analysis. Statistical analysis
of categorical data was performed
using the 2 test for contingency
tables with a 0.05 level of signifi-
cance using R software (R develop-
ment Core team 2008; R Founda-
tion for Statistical Computing,
Vienna, Austria; ISBN 3-900051-
07-0) was used to perform 2 tests.
RESULTS
Immature DCs were loaded with
the fast calcium indicator fluo-4 and were observed by conven-
tional epifluorescence microscopy in the absence of added
stimuli. Such cells display large rhythmic fluctuations of their
cytoplasmic Ca2 (Fig. 1A) with 40% of the cells exhibiting
oscillations with a frequency of one peak every 12.5 s (Table 1).
Interestingly, the addition of LPS (Fig. 1B) or of the TLR-7 ago-
nist (not shown) to iDCs did not affect the high frequency oscil-
lations nor did it cause any immediate changes in the [Ca2]i.
On the other hand, when mature DCs (treated with 1 g/ml
LPS for 18 h) were observed under identical conditions, the
high frequency oscillations were no longer present (Fig. 1C). In
the latter case of the 162 individual cells that were monitored,
FIGURE 1. Immature human dendritic cells show spontaneous Ca2 oscillations. Fluo-4-loaded dendritic
cells were allowed to deposit on poly-L-lysine-treated coverslips, and the changes in fluo-4 fluorescence were
monitored every 100 ms as described under “Materials and Methods.” Shown is a representative trace of the
oscillations observed in immatureDCs (A), in iDCs towhich 1g/ml LPSwas added (arrow) (B), in dendritic cells
treated with LPS (1 g/ml) overnight (mature DCs) (C), in iDCs pretreated with 2-APB for 45 min (D), in iDCs
pretreated with 2 M thapsigargin and 0.5 mM EGTA (E), and in iDCs treated with the PLC-inhibitor U73122 (2
M) (F). Traces are representative of experiments carried out on cells from five different donors. Results are
expressed as F/Fo, where F is the fluorescent value at any given time, and Fo is the initial fluorescence level
obtained at time 0.
TABLE 1
Characterization of spontaneous Ca2 oscillations in DCs
Frequency is represented as a percentage of cells with 1, 2–4, and 4–8 peaks during
50 s. Statistical analysis was performed using the 2 test. p 0.0001. All groups were
significantly different compared to iDC p 0.002.
Total no.
cells
1 peak/
50 s
2–4 peaks/
50 s
4–8 peaks/
50 s
% % %
iDC 83 8.30 51.70 40.00
iDC 100 M La3 60 36.70 45 18.33
iDC 0.5 mM EGTA 66 28.80 53.80 17.40
iDC 100 M 2-APB 116 100 0 0
iDC 1 M Xesto C 56 48.21 41 10.71
LPS-matured DC 162 100 0 0
TLR7-matured DC 266 70.00 20.00 10.00
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100% responded with a single, small increase of the [Ca2]i
within the 50-s measurement (Table 1). To determine the
source ofCa2 in the oscillations, iDCswere treatedwith (i) 100
M 2-APB, a blocker of store-operated Ca2 entry, and of
InsP3-mediated Ca2 release, (ii) 2 M thapsigargin, a SERCA
(sarco(endo)plasmic reticulum calcium ATPase) inhibitor that
leads to depletion of intracellular Ca2 stores, and (iii) 2 M
U73122, an inhibitor of phospholipase C. The addition of these
compounds completely abolished the spontaneous Ca2 oscil-
lations (Fig. 1,D–F). DCs were also incubated with other phar-
macological agents as shown in Table 1; the addition of 100 M
La3 or 0.5 mM EGTA significantly reduced the frequency of
oscillations from 40% cells showing 4–8 peaks/50 s to about
18% cells showing 4–8 peaks/50 s, indicating that Ca2 influx
plays some role in the oscillatory events. The addition of 1 M
Xestospongin C (an inhibitor of InsP3-mediated Ca2 release)
significantly diminished the frequency of the oscillations (Table
1) as well as the peak fluo-4 fluorescence in iDCs (Fig. 2). These
results strongly suggest that the oscillations are mainly due to
InsP3-mediated release of Ca2 from intracellular stores, with a
component (probably involved in store refilling) due to influx
from the extracellular environment. The phenotype of mature
DCs, on the other hand, was quite different irrespective of
whether the cells had been induced to mature via TLR-4 acti-
vation (by overnight incubation with 1 g/ml LPS) or via acti-
vation of TLR-7 (by overnight incubation with 3 M imidazo-
quinoline (3M-001)). In fact, LPS-matured DCs did not show
the high frequency oscillations but rather small and slow (1
peak/50 s) spontaneous fluctuations of their [Ca2]i. Interest-
ingly, incubation with imidazoquinoline, which does not trans-
mit a maturation signal as strong as that conveyed by LPS (see
CD83 expression in Fig. 5A), resulted in DCs with an interme-
diate phenotype; that is, with only a small proportion of cells
showing 2–8 oscillations/min whose magnitude is comparable
with that exhibited by iDCs (Table 1 and Fig. 2). The slow peak
Ca2 increase observed in mature DCs was reduced by more
than 50% by the addition of 100 M 2-APB (Fig. 2), whereas the
peak transient observed in the presence of Krebs-Ringer
medium containing no additional Ca2 and 0.5 mM EGTA was
not different from that observed in the presence of extracellular
Ca2 (1.79  0.31 and 2.10  0.35 F increase in Ca2 and
EGTA containingmedium respectively). These results indicate
that inmatureDCs as well, the slowCa2 transient ismainly do
to release from intracellular stores.
To directly determine whether Ca2 influx accompanies the
oscillations, we examined the DCs by TIRF microscopy, which
allows one to monitor changes in fluorescence occurring at the
plasmamembrane or withinmicrodomains close to the plasma
membrane. As shown in Fig. 3 oscillations are accompanied by
[Ca2]i influx in iDCs. Cells were allowed to attach onto the
glass coverslips, and the areas of attachment were identified
with the surface reflection interference contrast filter (Fig. 3,
panel B). This focal plane was fixed using the perfect focus
system, and changes in the [Ca2]i, which in this case represent
Ca2 events occurring at or very close to the plasmamembrane,
were monitored (Fig. 3, panel C). The pseudocolor images in
panel C represent the changes of fluo-4 fluorescence F (F/Fo)
at four time points, whereas panel D represents the kymo-
graphs of three selected cells (arrows in panel C) showing that
these changes in [Ca2]ioccur at different time points in differ-
ent cells during the 50 s of recording. The specificity of the
signal is demonstrated by the fact that the increase in fluo-4
fluorescence only occurs when cells are bathed in Krebs-Ringer
solution containing 2 mM Ca2 but is absent when cells are
bathed in Krebs-Ringer solution containing 100 M La3 (a
nonspecific blocker of plasma membrane Ca2 channels) or in
LPS-matured DCs (Fig. 3, panel E).
These results support the finding that oscillations of the
[Ca2]i are a specific feature of iDC that is lost upon differenti-
ation but convey little information as to their biological role.
We hypothesized that oscillations may be implicated in main-
taining the immature phenotype by acting on transcription fac-
tors, in particular on the Ca2-sensitive transcription factor
NFAT. To dissect the intracellular pathways directly down-
stream of the spontaneous Ca2 oscillations, we followed the
intracellular localization of endogenous NFAT in oscillating
iDCs or in DCs in which oscillations had been inhibited by
2-APB and in mature DCs. The cytosolic fraction of DCs was
obtained from untreated iDCs, iDCs treated for 15 and 45 min
with 2-APB, LPS-matured DCs, and iDCs treated with cyclos-
porine, a drug that reduces the nuclear translocation of NFAT
by inhibiting theCa2-dependent phosphatase calcineurin. Fig.
4A shows a representativeWestern blot and Fig. 4B shows a bar
graph of the intensities of the immunopositive bands of the
cytosolic content of NFATc1. LPS-matured DCs, which lack
the high frequency Ca2 oscillations, show the highest level of
cytoplasmic expression of NFAT. Similarly, its cytoplasmic
level is high in cyclosporine-treated iDCs but is significantly
reduced in the cytoplasm of untreated iDCs. Treatment of the
latter cells with 2-APB induced the cytoplasmic localization of
NFATc1. Fig. 4C shows the subcellular localization of NFATc1
by immunofluorescence; indeed, in iDCs a number of cells
exhibit nuclear distribution of NFAT (arrows), whereas iDCs
FIGURE 2.Magnitude of spontaneous Ca2 oscillations in DCs. The his-
tograms show the peak Ca2 transient (F/Fo) in untreated iDCs or cells
treated as indicated with 2-APB (100 M), Xestospongin C (Xesto; 1 M),
and LPS (1 g/ml 18 h). Experiments were performed on cells isolated
from at least four different donors, and results are expressed as the mean
(S.E.) peak in fluo-4 fluorescence of 26–145 cells. Statistical analysis was
performed using the ANOVA test followed by the Bonferroni post hoc test.
*, p  0.015; **, p  0.0005.
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treated with cyclosporine or in mature DCs the fluorescence
is distributed throughout the cytoplasm. These results indi-
cate that most of the transcription factor NFAT is targeted to
the nucleus in oscillating iDCs but that abrogation of Ca2
oscillations with 2-APB results in the preservation of NFATc1
within the cytoplasm. To determine whether this was specifi-
cally related to the transcription factor NFAT or a general
effect, we also followed the subcellular distribution of p65
(RelA), a component of the NF-B transcription complex (NF-
B1RelAIkB) detectable in the cytoplasm of iDCs that
translocates to the nucleus uponDCmaturation (12, 13, 26). As
shown in Fig. 4D, in LPS-maturedDCsNF-B is translocated to
the nucleus, whereas in iDCs it shows a cytoplasmic distribu-
tion. Blocking high frequency oscillations with 2-APB does not
result in the nuclear translocation of NF-B. Thus, the simple
abrogation of spontaneous Ca2 oscillations is not sufficient to
stimulate the cells to undergo maturation, whereas the oscilla-
tions appear to regulate nuclear targeting of NFAT and may be
intimately linked to the immature phenotype. The latter
hypothesis was tested by following the effect of abolishing the
high frequency oscillations on the transcription of several genes
characteristic ofmature DCs. As shown in Fig. 5A, iDCs exhibit
low transcription levels of CD80, CD86, CD83, interferon-,
and IL23A, genes that are characteristically transcribed in
matureDCs (1, 26, 31). Inhibition of high frequency Ca2 oscil-
lations with Xestospongin C or 2-APB caused a significant
(2–20-fold) increase in their levels of expression.
Finally we studied whether the high frequency oscillations
are linked to endocytosis, an essential phenotypic characteristic
of iDCs (2, 3), by comparing the capacity of iDCs, 2-APB-
FIGURE 3. Calcium influx in iDCs monitored by TIRF microscopy. Fluo-4 loaded iDCs were resuspended in Krebs-Ringer medium containing 2 mM Ca2 or
100MLa3andallowed toattach topoly-L-lysine-coatedglass coverslips.Onceattached, cellsweremonitoredbybrightfield (panelA)witha surface reflection
interference contrast filter to monitor glass coverslip/cell membrane attachment site (panel B) or by TIRF microscopy (panel C). Images in panel C show
pseudocolored ratiometric (F/Fo) changes in membrane-associated [Ca
2]i at four time points. Panel D shows the kymograph representation of the Ca
2
changes in50 s in3 selectedcells frompanel C.Panel E shows themean (S.E.) increase in fluo-4 fluorescence ratio (F/Fo) of iDCsbathed in2mMCa
2 containing
Krebs-Ringer medium (n 57 cells), in iDCs bathed in Krebs-Ringer medium containing 100 M La3 (n 45 cells), and in LPS-matured DCs (n 20 cells).
Experiments were performed on cells isolated from at least four different donors. **, statistical analysis was performed using the ANOVA test followed by the
Bonferroni post hoc test p 0.0002.
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treated iDCs, andmatureDCs to endocytose FITC-labeled dex-
tran. Fig. 5B shows that although 2-APB reduces the percentage
of FITC-positive cells by 40%, thus significantly reducing the
endocytic activity of iDCs, it does not result in a loss of endo-
cytosis comparable with that seen in mature DCs (loss of
80%). These results strongly suggest that abolishing the Ca2
oscillations generates a signal(s)
required for DC maturation.
DISCUSSION
Spontaneous Ca2 oscillations,
which are rhythmic changes in
[Ca2]i in the absence of stimula-
tion, have been reported in certain
types of excitable and non-excitable
cells such as mesenchymal stem
cells, endodermal cells, human astro-
cytoma cells, astrocytes, pancreatic
acinar cells, cardiac myocytes, oo-
cytes, and fibroblasts (19–21, 32–35),
although their intracellularmediators
and biological role(s) and the func-
tional consequence of their inhibition
have in many cases not been eluci-
dated. In the present study we show
that spontaneous Ca2 oscillations
also occur in human DCs and that
these Ca2 events are an exclusive
characteristic of cells in the imma-
ture stage. In fact, the addition of
LPS as well as maturation triggered
by other stimuli leads to the loss of
the spontaneous high frequency
Ca2 transients. A similar finding
concerning the loss of spontaneous
Ca2 oscillations induced by differ-
entiation was reported in human
mesenchymal stem cells upon dif-
ferentiation into adipocytes (19)
and in osteogenic cells upon differ-
entiation into osteoblasts (36, 37).
Interestingly, in stem cells Ca2
oscillations occur during the G1 to S
transition, suggesting their involve-
ment in cell cycle progression (38,
39). On the other hand, in vitro
monocyte-derived DCs do not ac-
tively proliferate but, rather, acquire
the biochemical and immunological
characteristics of naturally occur-
ring iDCs (5) indicating that in these
cells the oscillations are probably
not involved in cell division.
In immature dendritic cells, in-
tracellular Ca2 stores and InsP3 are
intimately connected with the high
frequency oscillations, as they were
completely abolished by depleting
stores with the Ca2-ATPase inhibitor thapsigargin (2 M) in
the presence of EGTA (0.5 mM). The lack of high frequency
Ca2 oscillations in mature LPS-treated DCs could not be
explained by different levels of expression of functional InsP3R
as mature DCs respond to ATP an InsP3-mobilizing agonist
(23) with a Ca2 transient of comparable magnitude in the
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mature and immature stage (results not shown). As to the intra-
cellular mediator(s) of the Ca2 oscillations, U73122, an inhib-
itor of phospholipase C (40), completely blocked Ca2 tran-
sients, whereas both 2-APB, a rather unspecific inhibitor of the
InsP3R also inhibiting Ca2 entry (41, 42), and Xestospongin C,
an inhibitor of InsP3R-mediated Ca2 release (43), significantly
decreased the frequency and magnitude of these events. The
differences in response to these compounds could be explained
by the contribution of Ca2 influx to the maintenance of the
Ca2 oscillations. To further address this question, we per-
formed intracellular Ca2 measurements in medium contain-
ing 2mMCa2 or in the presence of 100M La3 to block Ca2
entry. Under these conditions Ca2 fluctuations were still pres-
ent, but there was a reduction in the percentage of cells
showing high frequency (	4 transients/50 s) Ca2 tran-
sients. This result together with theTIRFCa2measurements
support the hypothesis that Ca2 influx is necessary to main-
tain the high frequency Ca2 oscillations characteristic of
immature dendritic cells through a refilling mechanism.
The most intriguing question arising from the observation
that monocyte-derived dendritic cells in the immature stage
show frequent Ca2 oscillations concerns the biological role(s)
of the oscillations. Inmacrophages, Ca2 oscillations have been
reported to accompany phagocytosis, suggesting a relationship
between Ca2 oscillations and uptake of foreign particles (44,
45). In vivo, immature DCs continuously sample their environ-
ment for foreign antigens, and indeed one of themain functions
of iDCs is antigen capture by endocytosis. We originally
FIGURE 4. Influence of Ca2 oscillations on the intracellular localization of NFAT andNF-B. A, shown is a representativeWestern blot of the cytoplasmic
fraction of iDCs treated as indicated and LPS (1 g/ml)-matured DC (mDCs). In each lane the proteins present in the cytoplasmic extract of 6 106 cells was
separated on 7.5% SDS-polyacrylamide gel and blotted onto nitrocellulose. The blot was cut into two; the upper portion (	60 kDa) was incubated with rabbit
anti-NFATc1 followed by peroxidase-conjugated anti-rabbit IgG. The lower portion was used as a control for protein loading and developed with -tubulin.
Immunopositive bands were visualized by chemiluminescence; indicates bands corresponding to NFAT. The experiment was repeated five times on DCs
from different donors. B, the intensity of the immunopositive bands from five experiments was quantified by densitometry using Bio-Rad GelDoc 2000; the
intensities were corrected for -tubulin content. Values are expressed as % intensity of immunopositive bands of mature DCs. Statistical analysis was per-
formed using the ANOVA test followed by the Bonferroni post hoc test. *, p 0.04; **, p 0.00005. C, shown is an immunofluorescence analysis of NFATc1
subcellular distribution in iDCs (untreated or treated with 2 M cyclosporine (CSA)) and mature DC. Cells were fixed with an ice-cold solution of acetone:
methanol (1:1) for 20 min at
20 °C. Cells were then incubated with rabbit anti-NFAT followed by Alexa fluor 488-labeled anti-rabbit IgG. Before mounting,
DAPI staining was performed to visualize nuclei. The scale bar indicates 25 m. Arrows indicate nuclear localization of NFAT in iDCs. D, NF-B subcellular
distribution in iDCs (untreated or incubated with 100M 2-APB for 45 min or with 1g/ml LPS for 60 min) is shown. Cells were fixed with an ice-cold solution
of acetone:methanol (1:1) for 20min at
20 °C. Cells were then incubatedwith rabbit anti- NF-B p65 polyclonal antibody followed by Alexa fluor 488-labeled
anti-rabbit IgG. Beforemounting,DAPI stainingwasperformed to visualize nuclei. The scale bar indicates 25m.Arrows indicatenuclear translocationofNF-B
in LPS-treated DCs.
FIGURE 5.Maturationmarkers of DCs after inhibition of oscillations. A, real-time PCR analysis of genes involved in DCmaturation in untreated cells or DCs
treated for 18 hwith Xestospongin C (1M), 2-APB (100M), TLR-7 agonist 3M-001 (3M), or LPS (1g/ml). Total RNAwas extracted from 1–2 106 cells, and
CD83, CD80, CD86, interferon-, and IL23A gene expression was evaluated by quantitative real-time PCR. Gene expression results are expressed as mean
(S.E.)-fold increase as comparedwith values obtained in iDCs treatedwithmedium. Pooled data are from experiments carried out on cells from five different
donors except for CD83 (DC3M-001), INF (DC2-APB, 3M-001, LPS), IL23A (DCXestoC, DC2-APB), where data from four donors were pooled, and CD83
(DC2-APB), where data from three donors were pooled. Statistical analysis was performed using the PROCMIXED SAS 9.2 statistical analysis program. *, p
0.0001; **, p 0.00025; ***, p 0.001. B, endocytosis of FITC-labeled dextran is shown. Cells treated as described for panel Awere plated in 12-well plate and
incubated at 37 °C for 30min with 0.5 mg/ml of FITC-labeled dextran. Negative controls were also incubated with FITC-labeled dextran but kept for 30min at
4 °C. Cells were washed 2 times with ice-cold phosphate-buffered saline and fixed with 1% paraformaldehyde, and the % of FITC-positive (ve) cells was
assessedby flowcytometry.Bar graphs represent themean (S.E.)%of fluorescent cells; fluorescent valueobtained for iDCwas considered100%. Results from
3–8 experiments from 3–8 different donors were pooled and averaged. Statistical analysis was performed using the ANOVA test followed by the Bonferroni
post hoc test. *, p 0.018; **, p 0.0003.
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hypothesized that the high frequency Ca2 oscillations may be
involved in activation of endocytosis, and blocking Ca2 oscil-
lations with 2-APB resulted in a significant but partial decrease
of FITC-dextran endocytosis, suggesting that the high fre-
quency oscillations may not be essential for endocytosis as
reported in embryonic stem cell-derived primitive endodermal
cells (20). Alternatively, the inhibitory effect of 2-APB may
reflect the fact that endocytosis is a Ca2-dependent event
requiring InsP3R activation and/or Ca2 influx (46, 47). On the
other hand, the involvement of Ca2 signaling in maturation
had been previously documented (26, 28), and it was shown
that DC maturation is enhanced by activation of ryanodine
receptor-mediated Ca2 release. The results obtained by real
time PCR strongly suggest that pharmacological interventions,
which decrease the high frequency oscillations, activate signals
that are necessary but not sufficient to induce full DC
maturation.
We next turned our attention to Ca2-sensitive transcrip-
tion factors as Ca2 oscillations have been shown to promote
the expression of specific genes in other cell systems (39, 48).
We focused our attention on NFAT, a calcineurin-dependent
transcription factor, as early work demonstrated that NFAT
has the remarkable capacity to sense dynamic changes in the
[Ca2]i and is especially tuned to detect high frequent Ca2
oscillations occurring within cells (48, 49). In fact, high fre-
quency oscillations have been shown to activateNFATby keep-
ing the transcription factor in the nucleus at high enough levels
to bind to enhancer sites long enough to allow initiation of
transcription. Because in our case only iDCs possess these high
frequency Ca2 fluctuations, NFAT should be active and trans-
located into the nucleus only in iDCs and not in LPS-matured
DCs. Western blot analysis of endogenous NFAT indeed
showed that the cytosolic fraction of iDCs contains consider-
able less immunopositive band compared with that present in
mature DCs; furthermore, by shutting off the Ca2 oscillations
with 2-APB, NFAT is retained in the cytoplasm. As opposed to
what was observed for NFAT, the transcription factor NF-B is
activated and translocated into the nucleus in LPS-matured
DCs but not in iDCs nor in 2-APB-treated DCs. Thus, simply
blocking the high frequency Ca2 oscillations or blocking
nuclear translocation of NFAT is not sufficient to induce either
nuclear translocation of NF-B or DC maturation.
Altogether these results indicate that the high frequency
Ca2 oscillations depend on the maturation stage of DCs, and
we suggest that they act as “frequency encoding” (as opposed to
amplitude encoding) signals, whereby through the activation of
NFAT, DCs maintain their immature phenotype. Our data do
not support recent results showing that LPS induces a transient
increase in [Ca2]i in DCs (50–52).We directly tested whether
the addition of LPS (1 g/ml) to iDCs causes an increase in the
cytoplasmic [Ca2]i but failed to obtain any response. Similarly,
no changes in the [Ca2]i on plasmamembrane microdomains
after the addition of LPS were observed by TIRF microscopy
(data not shown). The differences between our results and
those presented in Refs. 50–52 aremost likely due to the differ-
ent experimental models that were used; that is, humanmono-
cyte-derived DCs in this study versusmouse bone marrow-de-
rived DCs. In fact, as opposed to mouse DCs, immature human
DCs express very low levels of CD14, and thus, the CD14-de-
pendent Ca2 signaling pathways may be absent in our system.
Our possibility of using the TIRF microscope has enabled us to
directly monitor membrane-associated events, and our results
together with those of Matzner et al. (51) argue against a major
role of Ca2 influx in LPS-mediated Ca2 signaling.
In conclusion,we report that humanmonocyte-derived iDCs
exhibit spontaneous [Ca2]i oscillations that are linked to
InsP3R activation and to, a lesser extent, to Ca2 influx. These
high frequency events are lost duringmaturation and appear to
be an endogenous characteristic of the immature phenotype,
possibly activating nuclear translocation of NFAT and, thus,
enhancing the transcription of genes involved in maintaining
the cells immature. The results of the present investigation are
important because they point out novel aspects of intracellular
signaling in human DC and may open new areas of research
that could be developed in the future to help patients requiring
modulation of their immune response.
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